New hope for treating multiple sclerosis

Relatively new drugs now help some patients, but not others, with the most common form of multiple sclerosis. That may be because patients with the same symptoms experience different types of inflammation, suggests a new study in animals from the University of Michigan. If the differences are found in people, future treatments may be tailored to specific subtypes of the disease.